Finance

Beta
Lists
ENGN:NASDAQ
enGene Therapeutics Inc
$1.61
+0.62%
(+0.0100) 1D
Jun 11, 11:00:30 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ENGN...
Open
$1.61
High
$1.62
Low
$1.57
Mkt. cap
107.52M
Avg. vol.
2.85M
Volume
112.00K
52-wk high
$12.25
52-wk low
$1.40
EPS
-$2.25
Beta
-0.29
Shares outstanding
66.99M
No. of employees
82
Open
$1.61
High
$1.62
Low
$1.57
Mkt. cap
107.52M
Avg. vol.
2.85M
Volume
112.00K
52-wk high
$12.25
52-wk low
$1.40
EPS
-$2.25
Beta
-0.29
Shares outstanding
66.99M
No. of employees
82
Analyst outlook
Analyst Ratings
Based on 11 analysts giving stock ratings to ENGN in the past 3 months
Buy
Buy
3
Hold
8
Sell
0
12 month forecast
Based on 11 Wall Street analysts offering 12 month price targets for ENGN in the last 3 months.
Highest
Current $1.61
$21.50 (+1,235.40%)
Average
$5.93 (+268.32%)
Lowest
$2.00 (+24.22%)
News stories
From sources across the web
About enGene Therapeutics Inc
CEO-
Employees82
Founded-
Headquarters-
SectorBiotechnology
Websiteengene.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
20.21M
22.58M
31.72M
22.26M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.92M
7.37M
7.76M
8.93M
Operating expense
27.12M
29.95M
39.48M
31.18M
Total operating expenses
27.12M
29.95M
39.48M
31.18M
Operating income
-27.12M
-29.95M
-39.48M
-31.18M
Other non operating income
-
-280.00K
448.00K
-
EBT including unusual items
-25.58M
-28.75M
-38.38M
-29.75M
EBT excluding unusual items
-25.58M
-28.75M
-38.38M
-29.26M
Income tax expense
240.00K
239.00K
-497.00K
-
Effective tax rate
-0.94%
-0.83%
1.29%
-
Other operating expenses
-
-
-
-
Net income
-25.82M
-28.99M
-37.88M
-29.75M
Net profit margin
-
-
-
-
Earnings per share
-0.51
-0.57
-0.73
-0.44
Interest and investment income
2.49M
2.23M
1.98M
2.74M
Interest expense
-734.00K
-758.00K
-750.00K
-732.00K
Net interest expenses
1.75M
1.48M
1.22M
2.01M
Depreciation and amortization charges
-
-
-
-
EBITDA
-27.02M
-29.82M
-39.31M
-31.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer